Bolni Marius Nagalo

Closest collaborators

The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Omeed Moaven · 7 shared papers, 2024–2026 · strength 1.66
   • Paper The impact of the timing of adjuvant treatment initiation in patients with upfront resection of pancreatic cancer. DOI 10.1016/j.suronc.2025.102329↗
   • Paper Integrative Proteomic Analysis Reveals VMG Oncolytic Virus–Induced Molecular Reprogramming in Pancreatic Ductal Adenoca… DOI 10.21203/rs.3.rs-9943137/v1↗
   • Paper Pancreatic cancer tumor microenvironment is a major therapeutic barrier and target. DOI 10.3389/fimmu.2024.1287459↗
2. Conner Daniel Hartupee · 4 shared papers, 2024–2026 · strength 0.90
   • Paper Integrative Proteomic Analysis Reveals VMG Oncolytic Virus–Induced Molecular Reprogramming in Pancreatic Ductal Adenoca… DOI 10.21203/rs.3.rs-9943137/v1↗
   • Paper Pancreatic cancer tumor microenvironment is a major therapeutic barrier and target. DOI 10.3389/fimmu.2024.1287459↗
   • Paper Comparative Proteomic Profiling of Responses to Standard Systemic Treatment Regimens in Pancreatic Cancer. DOI 10.3390/cells15060531↗
3. Chiswili Yves Chabu · 3 shared papers, 2024–2026 · strength 0.71
   • Paper Pancreatic cancer tumor microenvironment is a major therapeutic barrier and target. DOI 10.3389/fimmu.2024.1287459↗
   • Paper Comparative Proteomic Profiling of Responses to Standard Systemic Treatment Regimens in Pancreatic Cancer. DOI 10.3390/cells15060531↗
   • Paper CMTM6-Silencing Microbial Immunotherapy Reprograms PDAC Tumors and Restores T-cell Function DOI 10.64898/2026.01.26.701790↗
4. Mitesh J. Borad · 3 shared papers, 2025–2026 · strength 0.70
   • Paper Integrative Proteomic Analysis Reveals VMG Oncolytic Virus–Induced Molecular Reprogramming in Pancreatic Ductal Adenoca… DOI 10.21203/rs.3.rs-9943137/v1↗
   • Paper Comparative Proteomic Profiling of Responses to Standard Systemic Treatment Regimens in Pancreatic Cancer. DOI 10.3390/cells15060531↗
   • Paper Resistance signatures to oncolytic vesiculoviruses in pancreatic ductal adenocarcinoma. DOI 10.1016/j.omton.2025.200937↗
5. Sudhakar Ammanamanchi · 2 shared papers, 2026 · strength 0.48
   • Paper Integrative Proteomic Analysis Reveals VMG Oncolytic Virus–Induced Molecular Reprogramming in Pancreatic Ductal Adenoca… DOI 10.21203/rs.3.rs-9943137/v1↗
   • Paper Comparative Proteomic Profiling of Responses to Standard Systemic Treatment Regimens in Pancreatic Cancer. DOI 10.3390/cells15060531↗
6. Amirsalar Mansouri · 2 shared papers, 2026 · strength 0.48
   • Paper Integrative Proteomic Analysis Reveals VMG Oncolytic Virus–Induced Molecular Reprogramming in Pancreatic Ductal Adenoca… DOI 10.21203/rs.3.rs-9943137/v1↗
   • Paper Comparative Proteomic Profiling of Responses to Standard Systemic Treatment Regimens in Pancreatic Cancer. DOI 10.3390/cells15060531↗
7. Jiří Adamec · 2 shared papers, 2026 · strength 0.48
   • Paper Integrative Proteomic Analysis Reveals VMG Oncolytic Virus–Induced Molecular Reprogramming in Pancreatic Ductal Adenoca… DOI 10.21203/rs.3.rs-9943137/v1↗
   • Paper Comparative Proteomic Profiling of Responses to Standard Systemic Treatment Regimens in Pancreatic Cancer. DOI 10.3390/cells15060531↗
8. Khandoker Usran Ferdous · 2 shared papers, 2024–2025 · strength 0.39
   • Paper Resistance signatures to oncolytic vesiculoviruses in pancreatic ductal adenocarcinoma. DOI 10.1016/j.omton.2025.200937↗
   • Paper Enhancing Neoadjuvant Virotherapy's Effectiveness by Targeting Stroma to Improve Resectability in Pancreatic Cancer. DOI 10.3390/biomedicines12071596↗
9. Aimée Galatas · 1 shared paper, 2026 · strength 0.32
   • Paper The impact of the timing of adjuvant treatment initiation in patients with upfront resection of pancreatic cancer. DOI 10.1016/j.suronc.2025.102329↗
10. Sydney McManus · 1 shared paper, 2026 · strength 0.32
    • Paper The impact of the timing of adjuvant treatment initiation in patients with upfront resection of pancreatic cancer. DOI 10.1016/j.suronc.2025.102329↗
11. John H. Stewart · 1 shared paper, 2026 · strength 0.24
    • Paper Comparative Proteomic Profiling of Responses to Standard Systemic Treatment Regimens in Pancreatic Cancer. DOI 10.3390/cells15060531↗
12. Paul de Figueiredo · 1 shared paper, 2026 · strength 0.23
    • Paper CMTM6-Silencing Microbial Immunotherapy Reprograms PDAC Tumors and Restores T-cell Function DOI 10.64898/2026.01.26.701790↗
13. Chelsae R Watters · 1 shared paper, 2025 · strength 0.22
    • Paper Resistance signatures to oncolytic vesiculoviruses in pancreatic ductal adenocarcinoma. DOI 10.1016/j.omton.2025.200937↗
14. Michael T. Barrett · 1 shared paper, 2025 · strength 0.22
    • Paper Resistance signatures to oncolytic vesiculoviruses in pancreatic ductal adenocarcinoma. DOI 10.1016/j.omton.2025.200937↗
15. Emmanouil Giorgakis · 1 shared paper, 2024 · strength 0.17
    • Paper Enhancing Neoadjuvant Virotherapy's Effectiveness by Targeting Stroma to Improve Resectability in Pancreatic Cancer. DOI 10.3390/biomedicines12071596↗
16. Michail N. Mavros · 1 shared paper, 2024 · strength 0.17
    • Paper Enhancing Neoadjuvant Virotherapy's Effectiveness by Targeting Stroma to Improve Resectability in Pancreatic Cancer. DOI 10.3390/biomedicines12071596↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.